Cancer

The research area in Cancer it has been structured in three distinct pillars: clinical research, laboratory translational research and innovation in cancer diagnosis and treatment.

Strategic lines

  • Research into new oncological therapies.
  • Study of biomarkers involved in the prognosis and prediction of the effectiveness of oncological treatments.
  • Research into new diagnostic tools based on artificial intelligence.

Objectives of the area

  1. Incorporation of new technologies in research projects.
  2. Start of new projects in molecular research and omic sciences.
  3. Incorporation of research personnel in the groups to generate more impact projects and scientific results.

Scientific production

50

Publications

25

Publications Q1

12

Publications D1

38%

Leadership

66%

Open access

6

Active competitive projects and Taulí Scholarships

3

New own studies initiated

3

Doctoral theses read

Outstanding scientific publications

Research staff

29

Gifts

18

homes

Research staff | doctor

Research staff | Predoctoral

Research staff | not doctor

Research staff (HRS4R) | R1

Research staff (H4S4R) | R2

Research staff (H4S4R) | R3

Research staff (H4S4R) | R4

Highlights of the area

GLIOSTAGE

Development of an artificial intelligence and deep learning system as a support tool in the imaging diagnosis of patients with gliomas.
IP: Silvia Gil.
Funding Entity: Intramural Program I3PT.

Improvement in the characterization of the tall cell subtype of papillary thyroid carcinoma

IP: Mª Rosa Bella. Funding Entity: Intramural Program I3PT

Mental Health and Neuroscience

The research area of Mental Health and Neuroscience is formed by a multidisciplinary group and they actively collaborate in national and international research networks, highlighting the leadership of a CIBERSAM group and the consolidation of the Mixed Unit with the UAB Neuroscience Institute since 2018.

Strategic lines

  • Application of new digital technologies in the diagnosis and treatment of mental health pathologies.
  • Prevention and promotion of mental health in the young and adult population.
  • Translational research for the development of markers and specific biomarkers for the diagnosis and treatment of mental health pathologies.

Objectives of the area

  1. Increase the number of research staff dedicated to research through new additions and loyalty of the research team through competitive contracts and structural funding.
  2. Start new projects in AI applied to the lines of research in the area.
  3. Promote digital innovation projects to implement them in the SNS.
  4. Maintain and expand the number of groups consolidated by the AGAUR within the area.
  5. Attract new collaborations through the TECSAM network.
  6. Improving the gender balance in the scientific leadership of the groups.

Scientific production

43

Publications

23

Publications Q1

12

Publications D1

44%

Leadership

67%

Open access

9

Active competitive projects and Taulí Scholarships

2

New own studies

1

Doctoral theses read

Outstanding scientific publications

Research staff

22

Gifts

16

homes

Research staff | doctor

Research staff | Predoctoral

Research staff | not doctor

Research staff (HRS4R) | R1

Research staff (H4S4R) | R2

Research staff (H4S4R) | R3

Research staff (H4S4R) | R4

Highlights of the area

INDICATIVE

The digital transformation in the prevention and management of the risk of suicide in adult patients through the use of AI algorithms, trained through clinical evidence.

IP: Diego J Palao

Funding Entity: State Research Agency – Ministry of Science and Innovation

The E-Mental Health group, prevention and epidemiology in neuropsychiatric diseases (e-MH-PEMN)

It receives recognition and funding from the Generalitat de Catalunya as a SGR-Cat 2021 research group

Metabolism and Digestive

The research area of Metabolism and Digestive includes leading professionals in metabolic and digestive pathologies, highlighting their participation in national and international projects and the leadership of a CIBERDEM group.

Strategic lines

  • Obesity, Prader-Willi Syndrome and hyperphagia.
  • Diabetes: cardiovascular risk and new technologies.
  • Inflammatory bowel disease.
  • Application of new digital and biotechnological technologies in the diagnosis and treatment of digestive metabolic diseases.

Objectives of the area

  1. Consolidation of collaborations with basic research groups to promote studies in omics and gene therapy.
  2. Increase the impact factor of the area.
  3. Reduce the number of publications in journals not indexed in the JCR.
  4. Participate in the Horizon Europe program.

Scientific production

47

Publications

25

Publications Q1

10

Publications D1

47%

Leadership

51%

Open access

16

Active competitive projects and Taulí Scholarships

9

New own studies

1

Doctoral theses read

Outstanding scientific publications

Research staff

26

Gifts

20

homes

Research staff | doctor

Research staff | Predoctoral

Research staff | not doctor

Research staff | support

Research staff (HRS4R) | R1

Research staff (H4S4R) | R2

Research staff (H4S4R) | R3

Research staff (H4S4R) | R4

Research staff (H4S4R) | rss

Highlights of the area

Discovery and early clinical development of new PDE-10 inhibitors for the treatment of Prader-Willi syndrome (PRAWILLI)

IP: Assumpta Caixàs

Funding entity: State Research Agency – Ministry of Science and Innovation

The Gastrointestinal Inflammation and Liver Diseases research group (GRIGMH)

It receives recognition and funding from the Generalitat de Catalunya as a SGR-Cat 2021 research group. It also receives a PERIS grant for the incorporation of a technical support profile for research in the amount of €81.000.

The research group Endocrinology, diabetes and metabolism

It receives recognition from the Generalitat de Catalunya as a SGR-Cat 2021 research group.

Rare Diseases

The research area of Rare Diseases it focuses on the research of diseases in which the Parc Taulí University Hospital is a center of reference for the diagnosis and treatment of the same.

Strategic lines

  • Study of minority diseases prevalent in our population: childhood obesity, genetic intellectual disability, Prader-Willi syndrome, Cystic Fibrosis.
  • Application of bioinformatics to improve diagnosis and treatment.
  • Study of disorders during puberty.
  • Childhood and juvenile diabetes.

Objectives of the area

  1. Promote the visibility of the scientific activity carried out by the research groups in the area.
  2. Increase leadership in competitive projects.
  3. Develop projects in collaboration with other groups and research centers that make it possible to generate impact.
  4. Promote training and the completion of doctoral theses in groups.
  5. Promote publication in journals with an impact factor and Open Access.

Scientific production

44

Publications

25

Publications Q1

13

Publications D1

39%

Leadership

80%

Open access

13

Active competitive projects and Taulí Scholarships

8

New own studies

1

Doctoral theses read

Outstanding scientific publications

Research staff

34

Gifts

17

homes

Research staff | doctor

Research staff | Predoctoral

Research staff | not doctor

Research staff | support

Research staff (HRS4R) | R1

Research staff (H4S4R) | R2

Research staff (H4S4R) | R3

Research staff (H4S4R) | rss

Highlights of the area

Effect of ivacaftor/tezacaftor/elexacaftor at pulmonary, nutritional and metabolic level in cystic fibrosis in a reference unit

IP: Laura Valdesoiro
Financing Entity: Cellers Maset – I3PT

Phase II clinical trial of an innovative therapy for patients with Fragile X Syndrome

IP: Ana Roche

Funding Entity: State Research Agency – Ministry of Science and Innovation

The research group Pediatric rare diseases group Taulí (PEDRAT)

It receives recognition from the Generalitat de Catalunya as a SGR-Cat 2021 research group.

Epidemiology, Care Improvement and Chronicity

The research area ofEpidemiology, care improvement and chronicity it is formed by a multidisciplinary group of professionals from the hospital, primary care and socio-health center.

Strategic lines

  • Study of the impact of infections by COVID-19 and other pandemics.
  • Improving chronic patient care.
  • Nursing assessment and care.
  • Quality, safety and traceability of patients treated by health services.

Objectives of the area

  1.  Consolidate the collaborations currently active in the area.
  2. Increase the visibility of the activity of the groups in the area.
  3. Increase collaboration between the groups in the area.
  4. Strengthen R+D+i relations with primary care.
  5. Promote the incorporation of groups into research networks.

Scientific production

45

Publications

21

Publications Q1

6

Publications D1

38%

Leadership

64%

Open access

18

Active competitive projects and Taulí Scholarships

9

New own studies

Outstanding scientific publications

Research staff

82

Gifts

15

homes

Research staff | doctor

Research staff | Predoctoral

Research staff | not doctor

Research staff | support

Research staff (HRS4R) | R1

Research staff (H4S4R) | R2

Research staff (H4S4R) | R3

Research staff (H4S4R) | rss

Highlights of the area

The research group Infermera Taulí to Care, Attract and Transform (RIT-CAT)

It receives recognition from the Generalitat de Catalunya as a SGR-Cat 2021 research group

Intensification of clinical research staff

Project: Breast 3D

IP: Mª Àngels Placeres

Funding Entity: Fundació Banc Sabadell – I3PT (Step up't Taulí)

Infections and Immunology

The research area d'Infections and Immunology promotes translational research in inflammatory and infectious diseases, clinical microbiology and immunology in order to optimize the diagnosis, treatment, prognosis and prevention of infectious diseases.

Strategic lines

  • Application of genomics, microbiology and proteomics in clinical research.
  • Application of new technologies such as artificial intelligence or Big Data analysis to develop techniques for early diagnosis and clinical decision support.
  • New research work methodologies in the network at different care levels.
  • Search for new biomarkers for the diagnosis and treatment of infectious, immune and inflammatory diseases.

Objectives of the area

  1. Encourage the realization of projects that include the study of omics.
  2. Increase collaboration between area groups.
  3. Implement in the SNS the results of the innovation projects currently active in the groups.
  4. Participate in new research networks and strengthen collaborative relationships that allow the groups' research to be consolidated.
  5. Incorporation of main researchers in the groups of the area.

Scientific production

155

Publications

96

Publications Q1

49

Publications D1

43%

Leadership

75%

Open access

57

Active competitive projects and Taulí Scholarships

19

New own studies

3

Doctoral theses read

Outstanding scientific publications

Research staff

68

Gifts

53

homes

Research staff | doctor

Research staff | Predoctoral

Research staff | not doctor

Research staff | support

Research staff (HRS4R) | R1

Research staff (H4S4R) | R2

Research staff (H4S4R) | R3

Research staff (H4S4R) | R4

Research staff (H4S4R) | rss

Highlights of the area

Integrated analysis of multi-omic data to establish clinical and molecular profiles predictive of the development of recurrent uveitis in patients with HLA-B27 positive ankylosing spondylitis. Study MOMPRUAA.

IP: Maria Llop
Funding entity: Instituto de Salud Carlos III (ISCIII)

FLIGHT: Fostering careers in the sciences of LIGHT

IP: Jaume Mesquida
Funding entity: European Commission – HORIZON-MSCA-2021-COFUND-01-01

Entropy Care: Digital solution based on the analysis of physiological waves for the prevention of extubation failure and self-extubation in critically ventilated patients

IP: Leonardo Sarlabous
Funding entity: PERIS Validation Tests (Generalitat de Catalunya)

The research group Transnational Research in Pathophysiology associated to critically Illness (RECII)

It receives recognition and funding from the Generalitat de Catalunya as a SGR-Cat 2021 research group. It also receives a PERIS grant for the incorporation of a technical support profile for research in the amount of €81.000.

The research groups Study of Community and Healthcare-Associated Infections (GrEICAAS), Interinstitutional Research Group on Respiratory Diseases Metropolitana Nord de Barcelona (RESPINORD) and Rheumatic Disorders Biomarkers Research (REDBIR)

They receive recognition from the Generalitat de Catalunya as SGR-Cat 2021 research groups.

Surgery and Interventional Procedures

The research area of Surgery and interventional procedures brings together professionals from different fields and disciplines with the aim of generating clinical application knowledge and generating technological innovations that improve healthcare practice.

Strategic lines

  • Application of new technologies for the reduction of invasive procedures.
  • Application of Artificial Intelligence in Big Data and image analysis to generate prediction and diagnostic algorithms.
  • Application of 3D printing technology to improve efficiency and quality in surgical procedures and interventions.

Objectives of the area

  1. Increase the implementation of the results in the health system, generating an impact on patients.
  2. Increase the scientific impact of the results: improve the level of publications and communications at national and international level.
  3. Explore new lines of research for the application of 3D technologies and artificial intelligence.
  4. Promote the generation of results that allow the consolidation of research groups in the area.

Scientific production

34

Publications

9

Publications Q1

4

Publications D1

62%

Leadership

62%

Open access

18

Active competitive projects and Taulí Scholarships

11

New own studies

1

Doctoral theses read

Outstanding scientific publications

Research staff

27

Gifts

32

homes

Research staff | doctor

Research staff | Predoctoral

Research staff | not doctor

Research staff | support

Research staff (HRS4R) | R1

Research staff (H4S4R) | R2

Research staff (H4S4R) | R3

Research staff (H4S4R) | R4

Research staff (H4S4R) | rss

Outstanding projects

AI4KIDNEY: Clinical Decision Support System based on Artificial Intelligence for the Integral Management of Chronic Kidney Disease

IP: José Ibeas.

Funding entity: PERIS Validation Tests (Generalitat de Catalunya)

Arteriovenous Fistula for Dialysis: Machine Learning based models for failure and Cardiac events (AI4FISTULA)

IP: José Ibeas

Financing entity: La Cauxa Banking Foundation (CaixaImpulse)

The Minimally Invasive Rectal Cancer Surgery (COLOPROCTO-TAULI) and Locomotor Research Group (ApLoc)” research groups

They receive recognition from the Generalitat de Catalunya as SGR-Cat 2021 research groups

Privacy preferences

When you visit our website, your browser may store information about specific services, usually in the form of cookies. Here you can change your privacy preferences. Please note that blocking certain types of cookies may affect your experience on our website and the services we offer.

Enable / disable Google Analytics tracking code
Enable / disable Google Fonts
Turn Google Maps on / off
Enable / disable embedded videos
This website uses cookies, mainly from third party services. You can edit your privacy preferences and / or accept the use of cookies.